HCA Healthcare Announces Operational Reorganization

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced an organizational change that includes the creation of a third operating group. The change, which will be effective January 1, 2023, is designed to enhance alignment with the company’s strategy, streamline areas that can improve long-term performance, and provide greater … [Read more…]

AHF Advocates to Ramp Up Gilead Protests Wednesday

Costumed Gilead Protest, Wed., October 26, 12:00 pm, Foster City, CA SAN FRANCISCO–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) will host a weeklong, twice-daily series of protests targeting drug maker of Gilead Sciences over the Bay Area company’s drug pricing and policies. The protesters, who have repurposed Gilead’s logo as “Greediad,” will start protesting each day at … [Read more…]

Endoluxe Joins NVIDIA Inception

MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe today announced it has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence. Endoluxe’s first product — used in minimally invasive surgery — is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge … [Read more…]

Assure Infusions Breaks Ground on Advanced Robotics Manufacturing Plant

60,000-square-foot facility will manufacture IV fluid products in Central Florida BARTOW, Fla.–(BUSINESS WIRE)–Assure Infusions, Inc., joined by local elected officials and area economic development representatives, broke ground last week on the company’s future fully-automated pharmaceutical manufacturing plant. “We’re excited for construction to begin soon and to be one step closer to opening our first facility,” … [Read more…]

Enveda Biosciences appoints industry leader Mark Deeg, M.D., Ph.D., as Chief Medical Officer

BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences today announced the appointment of Mark Deeg, M.D., Ph.D., as the company’s Chief Medical Officer. Dr. Deeg is a medical and pharmaceutical leader with broad experience developing drugs and digital therapeutics at companies from biopharma startups to pharmaceutical giants like Eli Lilly & Co., where he spent more than a decade. … [Read more…]

Buddha Brands™ Closes 5.25 Million Investment Funding with Fondaction

Innovator of Better-For-You Food & Beverages Announces Major Investment to Support Accelerated Growth and Expansion of Plant-Based Products in the Better-For-You Space MONTREAL–(BUSINESS WIRE)–Buddha Brands™, makers of better-for-you, plant-based snacks and beverages, today announced a $5.25 million round of funding from leading capital investor, Fondaction, whose commitment to the positive transformation of the local Quebec … [Read more…]

Mary Kay Announces Skin Health Grants and Delivers Eye-Opening Research on the Biology of Droopy Eyes at the 51st Annual European Society for Dermatological Research Meeting

DALLAS–(BUSINESS WIRE)–Mary Kay Inc., one of the world’s innovative skincare companies, has announced a new partnership with the European Society for Dermatological Research (ESDR) with its registered office in Geneva, Switzerland, to award grants to researchers at the 51st Annual ESDR Meeting. The congress took place between September 28 – October 1, 2022, in person … [Read more…]

ALYKA Health Launches Innovative Mobile Health Application

Private Healthtech Company to Deliver Digital Health Solutions at Scale ATLANTA–(BUSINESS WIRE)–#digitalhealth–ALYKA Health, a health technology company, announced today the launch of a mobile application that will serve as the digital health assistant for individuals and their families. ALYKA, available on iOS and Android devices, places the opportunity for better health into consumers’ hands. ALYKA … [Read more…]

The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program

64 physicians comprise Cohort II, bringing the total to 116 participants in the program’s second year PRINCETON, N.J.–(BUSINESS WIRE)–$BMY–The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University (VCU), the American Association for Cancer Research (AACR) and Gilead Sciences, Inc., today announced that an additional 64 physicians have been selected to receive the Robert … [Read more…]